Skip to content
Screener

G&A at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
$88.55M+28.3%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$41.53M-11.0%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$14.69M+7.8%
Certara, Inc. logo
Certara, Inc.CERT
$29.38M+49.5%
Sutro Biopharma logo
Sutro BiopharmaSTRO
$7.58M-42.9%
Septerna, Inc. logo
Septerna, Inc.SEPN
$8.45M+22.3%

Other financials

Income statement

See full
Revenue$58.9M+7.5%
Gross profit$32.4M+24.0%
Operating income-$41.5M+21.5%
Net income$6.0M+114%
EPS (diluted)$0.08+114%

Balance sheet

See full
Cash & equivalents$292.9M+26.3%
Total debt$108.0M-5.5%
Total equity$329.0M-4.1%
Total assets$640.4M-7.0%

Cash flow

See full
Operating cash flow-$34.1M
CapEx$362.0K+15.3%
Free cash flow-$34.4M

Valuation

See full
Market cap$1.4B+2.4%
Enterprise value$1.22B-2.7%
P/S5.4×-0.3×

Profitability

See full
Gross margin56.9%-1.6pp
Operating margin-59.2%-12.6pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.6×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Schrodinger’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001490978-26-000068
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating expenses:
Research and development40,99843,13884,82288,982
Sales and marketing10,26610,73421,86921,101
General and administrative (includes related party expense of $165, $109, $330 and $218)22,71525,18945,62950,991
Total operating expenses73,97979,061152,320161,074
Loss from operations(41,547)(52,903)(90,341)(103,792)
Other income (expense):
Change in fair value of equity investments45,8684,57932,381(8,516)

Item 1. Financial Statements.

FAQ

What is Schrodinger's G&A?
Schrodinger (SDGR) reported G&A of $22.72M in Q2 2026.
How has Schrodinger's G&A changed year-over-year?
Schrodinger's G&A decreased by 9.8% year-over-year, from $25.19M to $22.72M.
What is the long-term trend for Schrodinger's G&A?
Over 4 years (2021 to 2025), Schrodinger's G&A has grown at a 10.5% compound annual growth rate (CAGR), from $64.01M to $95.41M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Schrodinger's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude